Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GENOME EDITING

Nanoparticles for CRISPR–Cas9 delivery

Nature Biomedical Engineering volume 1, pages 854–855 (2017)Cite this article

Subjects

The DNA mutation that causes Duchenne muscular dystrophy in mice can be corrected, with minimal off-target effects, by gold nanoparticles carrying the CRISPR components.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Genome editing via nanoparticle-mediated delivery of the CRISPR–Cas9 machinery.

References

  1. Hsu, P.  D., Lander, E.  S. & Zhang, F. Cell 157, 1262–1278 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Doudna, J.  A. & Charpentier, E. Science 346, 1258096 (2014).

    Article  PubMed  Google Scholar 

  3. Tabebordbar, M. et al. Science 351, 407–411 (2016).

    Article  CAS  PubMed  Google Scholar 

  4. Nelson, C.  E. et al. Science 351, 403–407 (2016).

    Article  CAS  PubMed  Google Scholar 

  5. Long, C. et al. Science 351, 400–403 (2016).

    Article  CAS  PubMed  Google Scholar 

  6. Lee, K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0137-2 (2017).

  7. Ramadasan-Nair, R. et al. J. Biol. Chem. 289, 485–509 (2014).

    Article  CAS  PubMed  Google Scholar 

  8. Wang, M., Glass, Z.  A. & Xu, Q. Gene Ther. 24, 144–150 (2017).

    Article  CAS  PubMed  Google Scholar 

  9. Wang, H.-X. et al. Chem. Rev. 117, 9874–9906 (2017).

    Article  CAS  PubMed  Google Scholar 

  10. Yin, H., Kauffman, K.  J. & Anderson, D.  G. Nat. Rev. Drug Discov. 16, 387–399 (2017).

    Article  CAS  PubMed  Google Scholar 

  11. Staahl, B.  T. et al. Nat. Biotechnol. 35, 431–434 (2017).

    Article  CAS  PubMed  Google Scholar 

  12. Zuris, J.  A. et al. Nat. Biotechnol. 33, 73–80 (2015).

    Article  CAS  PubMed  Google Scholar 

  13. Wang, M. et al. Proc. Natl Acad. Sci. USA 113, 2868–2873 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ran, F. A. et al. Nat. Protoc 8, 2281–2308 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Engineering, Tufts University, Medford, MA, USA

    Zachary Glass, Yamin Li & Qiaobing Xu

Authors
  1. Zachary Glass
    View author publications

    Search author on:PubMed Google Scholar

  2. Yamin Li
    View author publications

    Search author on:PubMed Google Scholar

  3. Qiaobing Xu
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Qiaobing Xu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glass, Z., Li, Y. & Xu, Q. Nanoparticles for CRISPR–Cas9 delivery. Nat Biomed Eng 1, 854–855 (2017). https://doi.org/10.1038/s41551-017-0158-x

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41551-017-0158-x

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research